Fourpath Capital Management
ABBV icon

Fourpath Capital Management’s AbbVie ABBV Stock Holding History

Fourpath Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.17M Sell
4,487
-2,628
-37% -$674K 0.15% 95
2026
Q2 		$1.79M Buy
7,115
+1,714
+32% +$369K 0.24% 78
2026
Q1 		$1.17M Sell
5,401
-50
-0.9% -$11.1K 0.17% 95
2025
Q4 		$1.25M Sell
5,451
-2,706
-33% -$616K 0.17% 90
2025
Q3 		$1.89M Sell
8,157
-16
-0.2% -$3.26K 0.27% 72
2025
Q2 		$1.52M Buy
8,173
+454
+6% +$84.4K 0.24% 76
2025
Q1 		$1.62M Buy
7,719
+293
+4% +$57K 0.28% 71
2024
Q4 		$1.32M Buy
7,426
+876
+13% +$161K 0.24% 81
2024
Q3 		$1.29M Buy
6,550
+406
+7% +$75.8K 0.24% 80
2024
Q2 		$1.05M Sell
6,144
-314
-5% -$52K 0.78% 23
2024
Q1 		$1.18M Sell
6,458
-2,229
-26% -$384K 0.82% 23
2023
Q4 		$1.35M Buy
8,687
+582
+7% +$84.8K 0.91% 19
2023
Q3 		$1.21M Sell
8,105
-215
-3% -$31.6K 0.91% 25
2023
Q2 		$1.12M Sell
8,320
-1,231
-13% -$181K 1.35% 19
2023
Q1 		$1.52M Sell
9,551
-456
-5% -$69.7K 1.07% 15
2022
Q4 		$1.62M Sell
10,007
-418
-4% -$64.1K 1.18% 15
2022
Q3 		$1.4M Sell
10,425
-718
-6% -$103K 0.96% 22
2022
Q2 		$1.71M Sell
11,143
-3,872
-26% -$592K 1.06% 17
2022
Q1 		$2.43M Sell
15,015
-1,595
-10% -$232K 0.97% 22
2021
Q4 		$2.25M Buy
+16,610
New +$1.96M 0.86% 20

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Fourpath Capital Management's ABBV Position: Q3 2026 in Review

Fourpath Capital Management reduced its AbbVie (ABBV) stake by 37% in Q3 2026, selling an estimated $674K and leaving 4,487 shares worth $1.17M. The position accounts for 0.15% of the portfolio, ranked #95.

Fourpath Capital Management first reported a position in ABBV in Q4 2021 and has held it in 20 quarters since. The position peaked at $2.43M in Q1 2022. 1,092 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Fourpath Capital Management held 4,487 shares of AbbVie worth $1.17M as of Q3 2026.
  • Fourpath Capital Management sold 2,628 AbbVie shares in Q3 2026, an estimated $674K.
  • AbbVie made up 0.15% of Fourpath Capital Management's portfolio in Q3 2026, its #95 holding.
  • Fourpath Capital Management first reported a position in AbbVie in Q4 2021 and has held it in 20 quarters since.
  • Fourpath Capital Management's AbbVie position peaked at $2.43M in Q1 2022.
  • 1,092 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Fourpath Capital Management's 13F filing for Q3 2026, filed 19 Oct 2026.